Ardsley Advisory Partners LP Oncocyte Corp Transaction History

Ardsley Advisory Partners LP

  • $564 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$1.91 - $3.45 $22,809 - $41,199
-11,942 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$1.76 - $3.02 $21,017 - $36,064
11,942 New
11,942 $29,000

Others Institutions Holding OCX

# of Institutions
3
Shares Held
399K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $266M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Ardsley Advisory Partners LP Portfolio

Follow Ardsley Advisory Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Ardsley Advisory Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email